This isn’t the first study to link GLP-1s to reduced alcohol intake, according to Dr. Sue Decotiis, MD, a weight-loss doctor ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

Recent studies have found that Ozempic could lead to more muscle mass loss than traditional weight loss methods.

Losing weight on GLP-1 drugs like Ozempic isn't guaranteed. Experts reveal how to tell if yours isn't working and the next steps you should take to reach your weight loss goals.

These include knockoffs of popular weight loss drugs. Customs officials allowed CBS News a rare ... patients are aware that Novo Nordisk is the only company in the U.S. with FDA-approved medicines ...

The U.S. Food and Drug Administration has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a higher risk of inhaling gastric contents into ...

(Reuters) - Americans are still eagerly seeking prescriptions for Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO)'s weight-loss and diabetes drugs but ... to get off the FDA shortage list without ...

Novo Nordisk said on Friday its weight-loss drug met the main goal of a late-stage trial in ... But Madrigal Pharmaceuticals' Rezdiffra is the only approved treatment. "The long-term perspective ...

People with moderate osteoarthritis of the knee who took the drug weekly for ... under the name Wegovy for weight loss and Ozempic for diabetes, and the FDA has also approved it to reduce risks ...